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Background: Avian influenza virus (AIV) outbreaks are worldwide threats to both poultry and humans. Our previous
study suggested microRNAs (miRNAs) play significant roles in the regulation of host response to AIV infection in
layer chickens. The objective of this study was to test the hypothesis if genetic background play essential role in
the miRNA regulation of AIV infection in chickens and if miRNAs that were differentially expressed in layer with AIV
infection would be modulated the same way in broiler chickens. Furthermore, by integrating with parallel mRNA
expression profiling, potential molecular mechanisms of host response to AIV infection can be further exploited.
Results: Total RNA isolated from the lungs of non-infected and low pathogenic H5N3 infected broilers at four days
post-infection were used for both miRNA deep sequencing and mRNA microarray analyses. A total of 2.6 M and
3.3 M filtered high quality reads were obtained from infected and non-infected chickens by Solexa GA-I Sequencer,
respectively. A total of 271 miRNAs in miRBase 16.0 were identified and one potential novel miRNA was discovered.
There were 121 miRNAs differentially expressed at the 5% false discovery rate by Fisher’s exact test. More miRNAs
were highly expressed in infected lungs (108) than in non-infected lungs (13), which was opposite to the findings
in layer chickens. This result suggested that a different regulatory mechanism of host response to AIV infection
mediated by miRNAs might exist in broiler chickens. Analysis using the chicken 44 K Agilent microarray indicated
that 508 mRNAs (347 down-regulated) were differentially expressed following AIV infection.
Conclusions: A comprehensive analysis combining both miRNA and targeted mRNA gene expression suggests that
gga-miR-34a, 122–1, 122–2, 146a, 155, 206, 1719, 1594, 1599 and 451, and MX1, IL-8, IRF-7, TNFRS19 are strong
candidate miRNAs or genes involved in regulating the host response to AIV infection in the lungs of broiler
chickens. Further miRNA or gene specific knock-down assay is warranted to elucidate underlying mechanism of AIV
infection regulation in the chicken.
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Avian influenza virus (AIV) infection is a world-wide
threat to both human and avian species. AIV causes an
infection of the respiratory tract of the host, triggering a
cascade of innate and adaptive immune responses. Great
efforts have been made to develop new intervention
strategies to control AIV infections in chickens [1,2].* Correspondence: hzhou@ucdavis.edu
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reproduction in any medium, provided the orHowever, more effective measures against AIV infection
in the chicken are still needed. AI outbreaks in chickens
could not only cause dramatic economic losses to the
poultry industry, but also threaten human health. There-
fore, understanding host response to AIV infection and
chicken-virus interaction is not only essential to the
poultry industry, but also provides key insights into the
prophylactic and therapeutic protection for other influ-
enza hosts including humans.
miRNAs are short, 17–24 nt RNAs, which comprise a
large family of regulatory molecules found in almost alltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Number of reads of microRNAs from lungs of AIV
infected and non-infected chickens
Infected lung Non-infected
lung
High quality/both adapter 2,672,582 3,318,307
Exact match to known chicken miRNAs 2,314,793 2,875,366
Loose match to known chicken miRNAs 357,789 442,941
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demonstrated to have important functions in a variety of
biological processes and have been implicated in many
diseases including influenza, hepatitis and cancer [4-10].
miRNAs are capable of regulating mammalian immune
cell differentiation, the outcome of immune responses to
infection, and the development of diseases of immuno-
logical origins [11]. There are multiple mechanisms of
miRNA-mediated regulation of gene expression including
translational repression, disruption of mRNA stability,
miRNA-mediated deadenylation and inhibition of poly-
peptide elongation [12]. Determining how and when
miRNA suppress target mRNA gene expression remains
one of the greatest challenges in the field.
Through recognition of sequence-complementary tar-
get elements, miRNAs can either translationally suppress
or catalytically degrade both cellular and viral RNAs
[3,13]. Host miRNAs are able to impinge on viral life
cycles, viral tropism, and the pathogenesis of viral dis-
eases [14]. miRNAs can potentially regulate different
steps of a virus life cycle and abrogate toxicities of
replication-competent viruses [15-18]. For example,
human miR-32 represses the replication of the retrovirus
primate foamy virus type 1 (PFV-1) through the down-
regulation of replication-essential viral proteins encoded
by open reading frame 2 (ORF2) [16]. Based on compu-
tational prediction, human miR-136 and miR-507 have
potential binding sites at the polymerase basic 2 (PB2)
and hemmagglutinin (HA) proteins of H5N1 AIV, and
those two miRNAs may modulate AIV infection in
humans [19].
Next generation sequencing (NGS, deep sequencing)
has provided a powerful tool to identify differentially
expressed miRNAs especially low abundance ones under
conditions of physiological perturbation. We previously
used a Solexa Sequencer to identify differentially
expressed chicken miRNAs in AIV infected lungs and
trachea of layer type birds [20]. Genetics play a signifi-
cant role in host response to viral infection. We
hypothesize that gene expression of host cellular miR-
NAs following virus infection could be different between
different chicken genetic lines. There are two major
types of chickens: broilers (meat type chickens) and
layers (egg type chickens). In the current study, a deep
sequencing approach was employed to identify differen-
tially expressed miRNAs with AIV infection in broilers.
Identification of differentially expressed host miRNAs
is just the first step towards understanding miRNA regu-
lation of host-virus interactions, and then underlying
mechanisms that how genes targeted by differentially
expressed miRNAs mediate host-virus interaction would
be desired. Dissection of miRNA modulation of both
host and viral mRNA expression will provide insights in
the cellular mechanisms of host-virus interaction. Apowerful symbiosis between microarrays and NGS tech-
nologies has been witnessed [21]. Therefore, global gene
expression (mRNA) profiling of host response to AIV in-
fection was conducted to identify potential genes asso-
ciated with AIV infection using a chicken 44 K Agilent
microarray. We integrated predicted target genes infor-
mation (based on differentially expressed miRNAs) with
differentially regulated mRNA affected by AIV infection
to understand how miRNAs regulate mRNA gene ex-
pression with AIV infection in the chicken.
Results
Virus titers in lungs
Virus replication in lungs was examined using real-time
RT-PCR by measuring influenza virus matrix gene from
total RNAs at 4 days post inoculation (dpi). Virus titers
in the four infected chicken, determined by extrapola-
tion of real-time RT-PCR data, were 1.69, 3.41, 3.81, and
4.52 log10 EID50/ml. Lung samples from all 4 non-
infected chickens were negative.
miRNA sequences from small RNA libraries
A total of 2,672,582 and 3,318,307 filtered high quality
reads were obtained from infected and non-infected
chicken, respectively (Table 1). In the library from
infected chicken lungs, 2,314,793 of these reads were
exact matches and another 357,789 reads were loose
matches to known chicken miRNAs. In the library of
non-infected chicken lungs, 2,875,366 of these reads
were exact matches and another 442,941 reads were
loose matches to known chicken miRNAs. All reads with
a perfect match to mature miRNA sequences from
chicken deposited in miRBase version 16.0 (http://
microrna.sanger.ac.uk/) [22-24] with insertions or dele-
tions of 1–4 nucleotides at the 5’ and 3’ ends of miRNAs
were considered to represent Dicer-processing products
from each of the chicken miRNA precursors [20]. The
loose match reads were defined as no more than 4 nt
differences comparing to the known chicken miRNA
sequences determined as we did previously [20]. The
sum of exact and loose match reads was used as the
total number of reads for each miRNA.
Of the 499 distinct Gallus gallus (gga) miRNA entries
in miRBase [22-24], 272 miRNAs were identified in the
current chicken lung small RNA library. Also, one
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Table S1). Differential expression of this novel miRNA
“N1” and chicken miRNA miR-1711 were confirmed by
Northern blot analysis (Figure 1).
miRNA expression profiling analysis
miRNA expression profiles of infected and non-infected
chicken lungs were compared. Differentially expressed
miRNAs were identified (P < 0.05, Q < 0.05 and fold
change > 2) by Fisher’s exact test. Between infected and
non-infected lungs, 121 miRNAs were differentially
expressed. Of those, 43 miRNAs were unique to infected
lung and 8 miRNAs were unique to uninfected lung.
Sixty-five miRNAs were more highly expressed in
infected lungs, while 5 miRNAs were more highly
expressed in non-infected lungs (Table 2). With limited
biological replicates for the nature of next generation se-
quencing technology, there is no standard method avail-
able for this type of analysis. Two newly developed
methods (more conservative): DESeq and edgeR, were
implemented in this study. The differentially expressed
miRNAs are presented in Tables 3 and 4, there were 8
and 12 miRNAs differentially expressed (P < 0.05, fold
change > 2) by DESeq and edgeR, respectively, and all
these miRNAs were identified by the Fisher’s exact test
(Figure 2). Three out of eight miRNAs by DESeq ana-
lysis were also identified by edgeR. All miRNAs identi-
fied by DESeq were up-regulated with AIV infection. For
the 12 miRNAs identified by the edgeR program, nine
miRNAs specifically expressed in the infected chickens
and one miRNA in non-infected birds; two miRNAs
were up-regulated with AIV infection.
TaqMan miRNA assays were used to confirm two dif-
ferentially expressed miRNAs identified by deep sequen-
cing. There was general consistency between the
TaqMan assays and deep sequence analysis of miR-451
and miR-206 in terms of direction of regulation and stat-
istical significance (Figure 3). Specifically, there was a
2.05 fold up-regulation (7.25 fold in deep sequencingFigure 1 Confirmation of miRNAs. Northern blot analysis was
performed to confirm the presence of a novel miRNA (N1) and
another known chicken miRNA (gga-miR-1711) in infected and
non-infected chicken lungs. U6 probe was used as a control.analysis) in miR-451, and 4.71 fold down regulation
(2.86 fold in deep sequencing analysis) in miR-206 with
AIV infection in lungs (P < 0.05).miRNA target identification and validation
Potential targets of differentially expressed miRNAs were
predicted by the miRNA target prediction algorithm mi-
Randa 3.1 [25]. The entire list of immune target genes
related to AIV infection is listed in Additional file 2: Table
S2. One hundred and seventy-one immune related genes
were predicted to be targets of 35 differentially expressed
miRNAs. Each miRNA can target hundreds of genes. We
are especially interested in the targeted immune-related
genes; some immune related genes each had several pre-
dicted miRNA binding sites. For example, IL-17 receptor
D (Accession No.: AY278204), has predicted binding sites
for seven differentially expressed miRNAs: gga-miR-30b,
34a, 142-5p, 202, 460b-5p, 449b, and 460a. Interestingly,
first five miRNAs were up-regulated, while last two miR-
NAs were down-regulated following AIV infection. This
might explain why IL-17 receptor D was not differentially
expressed if these differentially expressed miRNA regulate
in different direction.
Of particular note, gga-miR-146a is one of differen-
tially expressed miRNAs that was associated with virus
infection in both broiler (current study) and layer chick-
ens [20]. Seven potential target genes (Table 5) of gga-
miR-146a were picked for the validation by a dual luci-
ferase reporter assay. The results are shown in Figure 4.
The 3’ UTR of five (ARL11, CHMP2B, POU1F1, PDHB
and HIF1AN) out of the seven genes targeted by miR-
146a showed significant suppression of Renilla luciferase
activity in RCAS-miR-146a infected cells relative to
those infected with RCAS-SC (P < 0.05). Inhibition of the
luciferase activity of significant targets varied between
65–85% amongst target sites.
Recent evidence indicates that cellular miRNAs can
also target viral genes [16]. Potential viral genes targeted
by differentially expressed miRNAs were predicted using
Vita program [26]. All of the AIV genes were predicted
to be targeted by at least one of up or down regulated
miRNAs (Table 6). For example, the gga-miR-34a, which
was only expressed in infected chicken lungs, not only
had 14 immune related target genes (Additional file 2:
Table S2), but also targeted the AIV HA, NA, PA, PB1
and PB2 genes. In general, more AIV genes were tar-
geted by induced host miRNAs than repressed miRNAs
(8.33 times higher). Some miRNAs had only two viral
targets, such as gga-mir-32 (targeting HA and NS genes)
and gga-miR-30b (targeting M and NA genes). Some dif-
ferentially expressed miRNAs had multiple predicted
viral targets, such as gga-miR-202 which is predicted to
target all nine AIV genes.
Table 2 Differentially expressed miRNAs between lungs of infected and non-infected chickens (P< 0.05, Q< 0.05 and
Ratio > 2) by Fisher’s exact test
miRNA Position on chromosomes Reads in infected Reads in non-infected Ratio infected/non-infected (Normalized)
gga-miR-1719 chr12:842924-843012 109 0 −1
gga-miR-1585 chr19:8800028-8800118 65 0 -
gga-miR-1777 chr28:2555498-2555592 24 0 -
gga-miR-460b-5p chr4:26873962687485 23 0 -
gga-miR-1716 chr5:60283968-60284072 22 0 -
gga-miR-3537 chr6:18024717-18024793 19 0 -
gga-miR-1718 chr5:33777662-33777741 18 0 -
gga-miR-1354 chr4: 3970359-3970439 18 0 -
gga-miR-1792 chr3:7712006-7712104 16 0 -
gga-miR-3535 chr9:16372628-16372709 15 0 -
gga-miR-1610 chr8:12398260-12398347 15 0 -
gga-miR-1631 chrZ:15789429-15789502 13 0 -
gga-miR-1805-5p chr1:135141607-135141690 12 0 -
gga-miR-1604 chr1:312691-312787 12 0 -
gga-miR-153 chr2:8765687-8765773 12 0 -
gga-miR-1593 chr1:61691788-61691877 12 0 -
gga-miR-3538-1 chrUn:44040736-44040810 10 0 -
gga-miR-3538-2 chr1:52608155-52608229 10 0 -
gga-miR-1723 chr2:41377973-41378078 10 0 -
gga-miR-1584 chrZ:18238506-18238570 10 0 -
gga-miR-1754 chr9:25014275-25014342 9 0 -
gga-miR-3528 chr17:8404342-8404438 9 0 -
gga-miR-1644 chr14:8284308-8284393 8 0 -
gga-miR-1745-1 chr24:5271413-5271449 8 0 -
gga-miR-1770 chr2:151547087-151547183 7 0 -
gga-miR-1809 chr8:23417849-23417956 7 0 -
gga-miR-34a chr21:3251514-3251622 7 0 -
gga-miR-1681 chr2:96361604-96361703 6 0 -
gga-miR-1692 chr9:23692587-23692675 6 0 -
gga-miR-1805-3p chr1:135141607-135141690 6 0 -
gga-miR-1463 chr5:11171642-1171751 6 0 -
gga-miR-1560 chr11:20587431-20587444 6 0 -
gga-miR-1700 chr1:140966218-140966317 6 0 -
gga-miR-1712 chr3:81937337-81937409 6 0 -
gga-miR-1772 chr6:11560478-11560546 6 0 -
gga-miR-1713 chr7:17384289-17384387 6 0 -
gga-miR-1781 chr14:3330762-3330854 6 0 -
gga-miR-1551 chr14:5233361-5233450 5 0 -
gga-miR-2127 chr1:170154815-170154918 5 0 -
gga-miR-3527 chrMT:8673-8781 5 0 -
gga-miR-3533 chrUn:20438961-20439044 5 0 -
gga-miR-3536 chr25:1478485-1478562 5 0 -
gga-miR-1785 chr11:20641236-20641337 5 0 -
gga-miR-1594 chrZ:75709-75799 473 17 34.54
gga-miR-1599 chr7: 25926968-25927029 184 7 32.64
gga-miR-1767 chr3:44732913-44732971 71 7 12.59
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Table 2 Differentially expressed miRNAs between lungs of infected and non-infected chickens (P< 0.05, Q< 0.05 and
Ratio > 2) by Fisher’s exact test (Continued)
gga-miR-1662 chr2:1721334-1721406 140 17 10.23
gga-miR-202 chr6:22813068-22813156 40 5 9.93
gga-miR-122-1 chrZ: 649337-649413 1952 279 8.69
gga-miR-1766-1 chr2:77319215-77319307 42 6 8.69
gga-miR-122-2 chrUn:12066796-12066872 1685 258 8.11
gga-miR-32 chr2:86506451-86506520 45 7 7.98
gga-miR-204-2 chr10:6651274-6651374 12 2 7.45
gga-miR-211 chr28:1784394-1784467 12 2 7.45
gga-miR-451 chr19: 5823968-5824036 207487 35518 7.25
gga-miR-19b chr1: 152248183-152248269 955 181 6.55
gga-miR-1694 chr7:5419755-5419852 26 5 6.46
gga-miR-1729 chr15:769596-769666 4292 843 6.32
gga-miR-1611 chr10:16350472-16350560 167 38 5.46
gga-miR-2188 chr22:2684926-2685094 7045 1800 4.86
gga-miR-18a chr1:152248626-152248718 88 23 4.75
gga-miR-1581 chr1:51158137-51158222 18 5 4.67
gga-miR-193b chr14: 759453-759535 159 47 4.20
gga-miR-1451 chr3:78710207-78710207 129 42 3.81
gga-miR-1587 chr19:1782806-1782901 15 5 3.72
gga-miR-1572 chr12:9668820-9668820 182 61 3.70
gga-miR-3523 chr13:8968882-8969047 65 22 3.67
gga-miR-18b chr4:3970228-3970311 70 24 3.62
gga-miR-155 chr1:105930213-105930275 40 14 3.55
gga-miR-454 chr15:399833-399953 31 11 3.50
gga-miR-15a chr1: 173700493-173700575 2413 861 3.48
gga-miR-144 chr19: 5824123-5824207 13216 4727 3.47
gga-miR-551 chr9:21966405-21966517 25 9 3.45
gga-miR-218-1 chr4:77774698-77774806 11 4 3.41
gga-miR-218-2 chr13:4322806-4322954 11 4 3.41
gga-miR-193a chr18: 6423770-6423846 1230 461 3.31
gga-miR-223 chr4: 232949-233048 1842 717 3.19
gga-miR-30b chr2:148331598-148331684 165 67 3.06
gga-miR-214 chr8:4739550-4739659 74 32 2.87
gga-miR-142-3p chr19: 496983-497070 1055 461 2.84
gga-miR-142-5p chr19: 496983-497070 1100 481 2.84
gga-miR-106 chr4: 3970359-3970439 897 394 2.83
gga-miR-16-2 chr9:23742791-23742884 1952 856 2.83
gga-miR-16-1 chr1: 173700351-173700434 2724 1206 2.80
gga-miR-1579 chr6:3677284-3677350 164 73 2.79
gga-miR-20a chr1: 152248306-152248403 426 190 2.78
gga-miR-1416 chrZ: 34596479-34596567 25 12 2.59
gga-miR-146a chr13: 7555593- 7555691 1331 639 2.59
gga-miR-1798 chr20:9654914-9655009 36 18 2.48
gga-miR-3531 chr23:417154-417240 22 11 2.48
gga-miR-20b chr4:3970047-3970131 734 378 2.41
gga-miR-1434 chr28:1055204-1055280 89 46 2.40
gga-miR-29a chr1: 3236329-3236417 205 108 2.36
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Table 2 Differentially expressed miRNAs between lungs of infected and non-infected chickens (P< 0.05, Q< 0.05 and
Ratio > 2) by Fisher’s exact test (Continued)
gga-miR-29c chr26: 2511658-2511746 205 108 2.36
gga-miR-24 chrZ:41158175-41158242 10052 5343 2.34
gga-miR-7b chrUn:38163821-38163930 251 134 2.33
gga-miR-17-5p chr1:152248781-152248865 1831 982 2.32
gga-miR-15c chr4:4049055-4049130 1002 538 2.31
gga-miR-1763 chr14:12895655-12895720 147 80 2.28
gga-miR-23b chrZ:41157406-41157491 15783 8718 2.25
gga-miR-147-1 chr1:12334922-12334991 92 52 2.20
gga-miR-17-3p chr1:152248781-152248865 1480 853 2.15
gga-miR-1800 chr5:47604931-47605006 98 58 2.10
gga-miR-458 chr13:8034158-8034273 69 41 2.09
gga-miR-92 chr1:152248070-152248417 13819 8291 2.07
gga-miR-7-1 chrZ:39554766-39554874 81 49 2.05
gga-miR-1705 chr17:9510405-9510494 26 16 2.02
gga-miR-7-2 chr10:14823525-14823623 71 44 2.00
gga-miR-1306 chr15:1296916-1296984 20 62 0.40
gga-miR-206 chr3: 110390439-110390514 28 98 0.35
gga-miR-301 chr15:406313-406405 5 19 0.33
gga-miR-1638 chr5:58712377-58712463 5 23 0.27
gga-miR-187 chr2:85892470-85892555 6 33 0.23
gga-miR-449b chrZ: 16040763-16040856 0 23 02
gga-miR-460a chr2:3583690-3583779 0 11 0
gga-miR-1765 chr18:5840573-5840677 0 9 0
gga-miR-216c chr3:288216-288301 0 7 0
gga-miR-1607 chr2: 45452355-45452433 0 6 0
gga-miR-1555 chr1:149148336-149148421 0 6 0
gga-miR-1c chr7:36625855-36625928 0 6 0
gga-miR-3529 chr10:14823529-14823619 0 6 0
Note: 1 Specifically expressed in infected lungs.
2 Specifically expressed in non-infected lungs.
Table 3 Differentially expressed miRNAs between lungs
of infected and non-infected chickens (P < 0.05 and
Ratio > 2) by DESeq
DESeq Fisher’s exact test
miRNA P-value Fold(I/C) P-value Fold(I/C)
gga-mir-1719 0.01 - 0.00 −1
gga-mir-1594 0.00 24.70 0.00 34.55
gga-mir-1599 0.02 23.33 0.00 32.64
gga-mir-122-1 0.01 6.21 0.00 8.69
gga-mir-122-2 0.02 5.80 0.00 8.11
gga-mir-451 0.01 5.19 0.00 7.25
gga-mir-19b 0.04 4.68 0.00 6.55
gga-mir-1729 0.03 4.52 0.00 6.32
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The genome-wide expression profiling of host response
to AIV infection was carried out using chicken 44 K
Agilent microarray. There were 508 genes differentially
expressed (161 up-regulated vs. 347 down-regulated) be-
tween AIV infected vs. non-infected chickens (P < 0.05,
Fold-change > 1.5). The fold-change of gene expression
between infected and non-infected group ranged from
34.33 to −10.10.
The integrative differentially expressed miRNAs and
mRNA expression of its potential targeted immune-
related genes are presented in Table 7. Eight immune
related host genes were significantly up or down regu-
lated with AIV infection. Four genes were significantly
up-regulated, while the rest were significantly down-
regulated. Chicken MX1 gene, which was reported to be
associated with influenza virus resistance [27], had the
highest fold-change (11.46 fold) followed by interleukin8 [28] (11.03 fold) and interferon regulatory factory 7
[29] (2.11 fold). Tumor necrosis factor receptor super-
family member 19 was down-regulated [30] (1.85 fold).
Table 4 Differentially expressed miRNAs between lungs
of infected and non-infected chickens (P < 0.05 and
Ratio > 2) by edgeR
edgeR Fisher’s exact test
miRNA P-value Fold(I/C) P-value Fold(I/C)
gga-mir-1719 0 433.20 0 −1
gga-mir-1585 0.01 258.74 0 -
gga-mir-1777 0.03 96.16 0 -
gga-mir-460b 0.03 92.20 0 -
gga-mir-1716 0.03 88.23 0 -
gga-mir-3537 0.04 76.34 0 -
gga-mir-1354 0.04 72.37 0 -
gga-mir-1718 0.04 72.37 0 -
gga-mir-1792 0.05 64.44 0 -
gga-mir-1594 0.02 26.96 0 34.54
gga-mir-1599 0.02 24.98 0 32.64
gga-mir-449b 0.03 −100 0 02
Note: 1 Specifically expressed in infected lungs.
2 Specifically expressed in non-infected lungs.
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mRNA expression were observed.
Gene ontology (GO) analysis
The significantly enriched functional terms in biological
processes from differentially expressed host genes and
predicted target genes of differentially expressed miR-
NAs with AIV infection, respectively, are presented inFigure 2 Integration of numbers of differentially expressed
miRNAs by different statistical methods. Differentially expressed
miRNAs were identified by Fisher exact test, DESeq and edgeR,
respectively (P < 0.05, fold change> 2).Additional file 3: Table S3. The immune related GO
terms are presented in Figure 5. Developmental process
(1.95 fold) was enriched by both target genes of
repressed miRNAs and induced mRNAs. Two immune
related GO terms, immune system process and immune
response, were only enriched by induced host genes.
GO terms significantly enriched in repressed genes
included four clusters: cytoskeleton-dependent intracel-
lular transport, DNA unwinding during replication
microtubule-based movement and response to DNA
damage stimulus. For GO terms significantly enriched in
targets of induced miRNAs, five GO terms were
enriched. These included calcium ion transport; homo-
philic cell adhesion; T cell activation; gamma-
aminobutyric acid signalling pathway; and Wnt receptor
signalling pathway.
Discussion
Integration of global profiling of miRNAs and mRNA
expression may provide a unique opportunity in enhan-
cing our understanding of regulatory mechanisms in
many biological processes including virus infection.
Identification of differentially expressed miRNAs asso-
ciated with AIV infection is the first critical step of this
comprehensive analysis. With limited number of bio-
logical replicates, and the nature of distribution of
discrete measurement data other than continuous vari-
able in microarray data, no single statistical method cur-
rently available can meet all conditions of this type of
data [31]. As the main purpose of this step was to nar-
row down a small set of differentially expressed miRNAs
that are potentially associated with AIV infection, our
strategy was to include any potential important miRNAs
(relative loose criteria with potential high false positive
rate) for global enrichment analysis, but more conserva-
tive for further analysis for individual miRNA. Therefore,
we chose three methods that have been intensively used
for next generation sequencing data analysis [32-34], in-
cluding Fisher’s exact test, DESeq and edgeR. Based on
the results, Fisher’s exact test is less stringent than both
DESeq and edgeR. On the other hand, both DESeq and
edgeR might be too conservative. For example, gga-miR-
206 was not identified by DESeq, neither by edgeR, but
it was confirmed by real-time RT-PCR. This did suggest
that the criteria used in the DESeq and edgeR analyses
might miss some true positive, although this may ex-
clude potential false positives. Thus, for the following
global functional term enrichment analysis, our analysis
was primarily based on the results from Fisher’s exact
test. However, we are more interested in the 17 miRNAs
(Tables 2, 3 and 4) that were identified as significant in
at least two of the three methods of analysis, and espe-
cially the three miRNAs (gga-mir-1719, 1594 and 1599)
identified across all three analysis. Of particular note,
Figure 3 Validation of two differentially expressed miRNAs by TaqMan miRNA assays. Two differentially expressed miRNAs (gga-miR-206
and 451) identified by deep sequencing were confirmed by using TaqMan miRNA assays.* P <0.05.
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http://www.biomedcentral.com/1471-2164/13/278these three miRNAs are chicken specific miRNAs. To
our knowledge, this is the first report of potential func-
tion study of these three miRNAs in animals. Further in-
vestigation of underlying mechanisms of these miRNAs
in regulating AIV replication will expand our knowledge
in host-pathogen interaction in animals.
Genetics play an important role in the regulation of
miRNAs expression in animals [35]. We hypothesize
that genetics affect the regulation of miRNA expression
during AIV infection in the chicken. In the present studyTable 5 Potential gga-miR-146a targets
Symbol/GI gga-miR-146a:mRNA(3’UTR) interaction
HIF1AN/118092762 3' UUGGGUACCUUAAGUCAAGAGU 5'
|:|:: ||| || ||||||||
5'AGCTTCTGG–TTGAGTTCTCA 3'
PDHB/118097022 3' UUGGG--UACCUUAAGUCAAGAGU 5'
|:||: | || | ||||||||||
5'AGCCTAAAAGGCA-TCAGTTCTCA 3'
LATS1/118088356 3' UUG–GGUACCUUAA——GUCAAGAGU 5'
|:| |::||||| | :||||||||
5' AGCTGCTGTGGAAATGGCATAGTTCTCA 3'
POU1F1/45383513 3' UUGGGUACCUUAAGUCAAGAGU 5'
| :|: | |: | ||||||||
5'ACTCTCTTCAGGT-AGTTCTCA 3'
CHMP2B/71896762 3' UUGGGUAC-CUUAAGUCAAGAGU 5'
|| :| || |||| |||||||||
5'AAGTC-TGAGAATGCAGTTCTCA 3'
ARL11/118084874 3' UUGG-GUA—CCUUAAGUCAAGAGU 5'
||| ||| ||| ||||||||
5'GACCGCATATAGGA——AGTTCTCA 3'
MAP3K3/118102843 3' UUGGGU——A-CCUUAAG——UCA-AGAGU 5'
::|||| | ||||| : ||| |||||
5'GGCCCAAGAGTGGGAATGTAAGAAGTGTCTCA 3'
Note: * The 3’UTR predicted target genes containing gga-miR-146a binding sites wewith broiler chickens, there were more miRNAs up-
regulated than down-regulated with virus infection,
which was the opposite with our previous miRNA profil-
ing in layer chickens with AIV infection (more down-
regulated than up-regulated) [20]. Table 8 lists differen-
tially expressed miRNAs in both current broiler and pre-
vious layer studies. Only two (miR-1599 and miR-1416)
of eighteen miRNAs had consistent directions of regula-
tion following AIV infection, which suggests that these
two miRNAs were conserved responses to AIV infectionmiRanda score/energy (kcal/mol) Binding site Insert location*
167/-18.0 2261-2280 1959-2417
168/-22.3 3732-3754 3365-3864





re cloned into the 3’UTR of the psiCHECK-2 vector (Promega).
Figure 4 Validation of miR-146a target genes in the Renilla luciferase reporter system. Seven potential miR-146a target genes predicted by
the miRanda algorithm were chosen for validation. For each predicted target gene a luciferase reporter vector was constructed in which the
predicted miR-146a binding site was cloned into the 3’ UTR of a Renilla luciferase reporter gene. The Renilla luciferase activities were normalized
to Firefly luciferase activities (under the control of an independent promoter). The relative expression of each Renilla luciferase target construct
was compared between cells expressing miR-146a and those expressing the scrambled control sequence (SC) using a t-test for statistical
significance (p < 0.05). Error bars indicate standard deviation. CASP6, a gene containing no binding site for miR-146a but predicted to contain a
miR-143 target site was used as negative control.
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http://www.biomedcentral.com/1471-2164/13/278across diverse genetic lines. The major discrepancies be-
tween two studies might be due to: broilers and layers
being genetically distinct chicken breeds with long-term
diverse selection targeting on growth and egg produc-
tion, respectively. Specifically, broilers are specialized in
the production of a short term humoral response, while
layers have a long-term humoral response in combin-
ation with a strong cellular mediated response [36]. The
differential expression of miRNAs between them may re-
flect different miRNA-mediated host responses to virus
infection. For example, differential expression of miR-
142-3p in conventional CD4+ T cells and CD25+ TREG
cells in mice control the functions of both effector and
suppressor cells. In the current study, gga-miR-142-3p
was down-regulated in layers and up-regulated in broi-
lers, which indicate that host immune response to AIV
infection mediated by gga-miR-142-3p in broiler chick-
ens may be different from layer. In summary, although
other factors such as time of challenge may contribute
to great miRNA difference between broilers and layers,
these results strongly suggest that genetic backgrounds
play a vital role in the regulation of miRNAs during AIV
infection in chickens.
The miR-155 has been reported to play important
roles in both innate and adaptive immunity in mammals
[7,37,38]. miR-155 knock-out mice are not capable of
generating defensive immune responses, developing lym-
phocytes, or antigen-presenting cell functions [39]. The
up-regulation of miR-155 with poly (I:C) and IFNβ
stimulation in mouse macrophages suggest an importantrole of miR-155 in the regulation of viral infection [37].
In the current study, gga-miR-155 was significantly
induced by AIV infection, which was consistent with
other studies [40]. Based on target prediction, miR-155
could target the chicken anti-influenza gene MX1, there-
fore playing a role in host and AIV interactions in chick-
ens. The activation of c-Jun NH2-terminal kinases (JNK)
pathway can eliminate virus-infected cells by apoptosis.
The inhibition of JNK pathway blocked the expression
of miR-155 in murine macrophages [37,40]. Down-
regulation of TNFRSF19 (TNF receptor superfamily
member 19), one of key genes in JNK pathway, indicate
that antiviral activities through JNK pathway might be
inhibited. Therefore, up-regulated miR-155 might also
activate JNK pathway, and subsequently induce apop-
tosis to eliminate virus infected cells [37,40].
Most of the up-regulated miRNAs were predicted to
target the hemaglutinin (HA) and neuraminidase (NA)
mRNAs such as miR-34a and miR-155. Both HA and
NA are major surface glycoproteins. HA is responsible
for receptor binding and virus fusion [41], while NA is
responsible for receptor destruction and virion release
[41]. Therefore, induction of these miRNAs might affect
virus attachment and release and therefore the formation
of new infectious viral particles. In addition, three down-
regulated miRNAs (miR-206, miR-301 and miR-187) also
were predicated to target on AIV genome. The first line
of evidence from this integrative analysis strongly indi-
cates that the importance of several candidate miRNAs
including miR-34a, 146a, 155 and 206 warrant further
Table 6 AIV viral targets of differentially expressed miRNAs between lungs of infected and non-infected chicken
(P <0.05, Q< 0.05 and Ratio > 2)
miRNA Ratio of Infected/Non-infected (Normalized) AIV RNA segments
gga-miR-153 Specifically expressed in infected lung HA, NA, PA, PB1 and PB2
gga-miR-34a Specifically expressed in infected lung HA, NA, PA, PB1 and PB2
gga-miR-202 +9.93 HA, M, NA, NP, NS, PA, PB1 and PB2
gga-miR-32 +7.98 HA and NS
gga-miR-211 +7.45 HA, M, NA, NP, NS, PA, PB1 and PB2
gga-miR-19b +6.55 HA, NS, PA and PB1
gga-miR-18a +4.75 HA, M, NA, PB1 and PB2
gga-miR-18b +3.62 HA, M, NA, PB1 and PB2
gga-miR-155 +3.55 HA, NA, NP, NS and PB1
gga-miR-15a +3.48 HA, M NP, NS and PB2
gga-miR-223 +3.19 HA, NA, PB1 and PB2
gga-miR-30b +3.06 M and NA
gga-miR-142-3p +2.84 HA, NA, PA, PB1 and PB2
gga-miR-106 +2.83 HA, NA, PA, PB1 and PB2
gga-miR-20a +2.78 HA, NA, NP, PB1 and PB2
gga-miR-146a +2.59 HA, M, NA, NP, NS, PA, PB1 and PB2
gga-miR-20b +2.41 HA, M, NA, NP, NS, PB1 and PB2
gga-miR-29a +2.36 HA, M, NA, NP, PA, PB1 and PB2
gga-miR-29c +2.36 HA, M, NA, NP, PA and PB1
gga-miR-24 +2.34 HA, M, NA, NP, NS, PA, PB1 and PB2
gga-miR-7b +2.33 HA, M, NA, PA, PB1
gga-miR-17-5p +2.32 HA, M, NA, NP, PA, PB1 and PB2
gga-miR-23b +2.25 HA, M, PA and PB1
gga-miR-17-3p +2.15 HA, M, NA, NP, PA and PB2
gga-miR-92 +2.07 HA, M, NP, NS, PB2
gga-miR-206 −2.86 HA, NA, NP, PB1 and PB2
gga-miR-301 −3.03 HA, NA, PB1 and PB2
gga-miR-187 −4.35 NA, NP, PB1 and PB2
Note: + Up-regulated with AIV infection; - Down-regulated with AIV infection.
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regulation of AIV infection in chickens.
Conclusions
In summary, this comprehensive analysis has provided
several lines of new evidence on how host miRNA might
regulate host response to AIV replication in broilers.
Specifically, this study generated a list of strong candi-
date miRNAs including miR-34a, 122–1, 122–2, 146a,
155, 206, 1719, 1594, 1599 and 460 that potentially regu-
late AIV infection in chickens. In addition, several candi-
date genes including MX1, IL-8, IRF-7, TNFRS19 have
been identified to be associated with AIV infection in
broilers. Finally, comparison with our previous layer
miRNA profiling, this study strongly indicates that gen-
etic background is a critical factor in determining
miRNA abundance and regulation during AIV infection.As main focus of this global profiling analysis was to
generate new hypothesis by screening whole genome
miRNAs and mRNAs, our on-going effort using experi-
mental approach such as knock-down or over-express
candidate miRNAs and mRNAs in vitro is expected to
provide new evidence in understanding these regulatory
mechanisms of AIV infection in chickens.
Methods
Sample collection and RNA isolation
Day old broilers (Cobb-Vantress, Inc.) were randomly
divided into two groups (4 chickens per group), housed in
negative pressure Horsfall-Bauer, temperature control iso-
lation units and provided with water and commercial feed
ad libitum. At one week of age, one group was inoculated
with 0.1 ml of CK/TX/02/H5N3 virus containing107.5
EID50/ml and the remaining chickens were inoculated
Table 7 Differentially expressed immune related host mRNAs between lungs of infected and non-infected chickens
(P <0.05 and Fold-change >1.5)
Gene description Gene Accession Infected vs. Non-infected
(Fold-change)
miRNA1 (fold change)
MX1 myxovirus (influenza virus) resistance 1[27] Z23168 +11.46 gga-miR-155(+3.55)
gga-miR-206(−2.86)
Interleukin 8 (IL8) [28] M16199 +11.03 gga-miR-32(+7.98)
Interferon regulatory factor 7 (IRF7)[29] U20338 +2.11 gga-miR-142-5p(+2.84)
Interleukin1receptor-like1, transcript variant1[51] AB041738 +1.65 gga-miR-460 (only expressed in infected lungs)
TNF receptor superfamily, member 19[30] BX931334 −1.85 gga-miR-187(−4.35)
Tipartite motif-containing 7.1[52] BX934475 −1.81 NA2
RAC serine/threonine-protein kinase3 (ATK3)[53] BX950472 −1.65 NA
C-fringe 1[54] U97157 −1.52 NA
Note: 1miRNAs targeting on differentially expressed immune related genes; 2 No miRNAs targeting on the gene; +: Up-regulated with AIV infection; –: Down-
regulated with AIV infection.
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route. At 4 days post-inoculation (dpi), depression and se-
verely congested lungs were observed in the treated chick-
ens. Therefore, all chickens were humanely euthanized at
4 dpi, and lungs were collected for RNA isolation. The
animal experiment was performed according to the guide-
lines approved by the Institutional Animal Care and Use
Committee, Texas A&M University.
Two pools of total RNA samples (2 random chickens
per pool) were generated from the infected and non-
infected group. Total RNAs were isolated using Trizol
(Invitrogen, Carlsbad, CA) following the manufacturer’sFigure 5 Gene ontology (GO) annotation of differentially expressed g
between lungs of AIV infected and non-infected chicken in biological
dividing user’s percentage by the percentage of each category of the whoprotocol. Dnase I (Ambion, Austin, TX) digestion was
carried out after RNA isolation according to manufac-
turer’s instructions. RNA concentration and purity were
determined by measuring absorbance at 260 nm and
A260/A280 ratio using a NanoDrop ND-1000 spectro-
photometer (Nanodrop Technologies, Wilmington, DE).
RNA samples were stored at −80°C until further use.
Viral titration
Virus titers in lungs of inoculated chickens were
determined at 4 dpi by real-time RT-PCR of influenza
virus matrix gene using AgPath-ID™ AIV- M kitenes and target genes of differentially expressed miRNAs
process category (P < 0.05). Fold enrichment is a ratio obtained by
le genome.
Table 8 Comparison between layer and broiler miRNA deep sequencing results (P < 0.05, Q<0.05 and Ratio > 2)
miRNAs Layers Broilers
Infected Non -infected Ratio (Normalized) Infected Non -infected Ratio (Normalized)
Inconsistent gga-mir-106 0 27 + 897 394 2.83
gga-mir-142-3p 2 49 0.07 1055 461 2.84
gga-mir-142-5p 2 49 0.07 1100 481 2.84
gga-mir-144 111 94 0.21 13216 4727 3.47
gga-mir-146a 7 105 0.12 1331 639 2.59
gga-mir-15a 2 102 0.04 2431 861 3.48
gga-mir-16-1 1 107 0.02 2724 1206 2.80
gga-mir-1729 0 24 + 4292 843 6.32
gga-mir-19b 1 31 0.06 955 181 6.55
gga-mir-193a 5 26 0.35 1230 461 3.31
gga-mir-206 101 9 20.38 28 98 0.35
gga-mir-20a 1 23 0.08 426 190 2.78
gga-mir-20b 0 10 + 734 378 2.41
gga-mir-223 1 15 0.12 1842 717 3.19
gga-mir-29a 2 15 0.24 205 108 2.36
gga-mir-451 93 1287 0.13 207487 35518 7.25
Consistent gga-mir-1599 48 13 6.17 184 7 32.64
gga-mir-1416 17 10 3.09 25 12 2.59
Note: + Specifically expressed in non-infected lungs.
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instructions. For quantitation of virus load, RNA was
extracted from serially diluted H5N3 virus stock
(101.5–105.5 log10 EID50/ml) and used to generate a
standard curve. The amount of RNA in the samples
was converted into log10 EID50/ml by interpolation as
described previously [42].
Small RNA sequencing and analysis
For small RNA library construction, total RNA samples
from lungs of infected and non-infected broiler chickens
were prepared using the DGE-Small RNA Sample Prep
Kit (Illumina, San Diego, CA) as previously described
[20]. A total of two Solexa-ready small RNA templates
were analyzed on an Illumina 1 G Genome Analyzer at
the University of Houston. Cluster generation was per-
formed and clusters were sequenced. Initial sequence
process and analysis was done as previously described
[20]. All unique sequence reads with a minimum read
count of 5 were aligned with precursor chicken miRNA
sequences from miRBase version 16 [22-24]. Reads of
each miRNA were the sum of exact and loose matches
(± 4 bp) to known miRNAs. For each sample, counts
were normalized to the total number of small RNA
sequences, and then for each miRNA, the normalized
number of counts was compared between groups. False
discovery rate (FDR) (Q values) was calculated by Rprogram according to Benjamin’s method [43]. Fisher’s
exact test, DESeq [33] and edgeR [32] were used to iden-
tify differentially expressed miRNAs (P < 5%). Fold
changes for Fisher’s exact test were calculated as the
ratio of normalized reads of infected over non-infected
group. Statistics related to over representation of func-
tional categories were performed using DAVID [44-46].
A P < 0.05 was considered significant. Novel miRNAs
were identified using the methods of Creighton et al.
and Wang et al. [20,47].
Confirmation of miRNA expression by northern-blot
Expression of one potential novel miRNA was confirmed
by Northern blot analysis using the same total RNA
samples as those used for small RNA library construc-
tion. Total RNA of infected and non-infected lung sam-
ples (15 μg each) were separated on a 15% denaturing
acrylamide gel and transferred onto a GeneScreen Plus
nylon membrane (GE Healthcare, Piscataway, NJ). Mem-
branes were fixed by UV cross-linking at 1200 μJ and
baking at 80°C for 1 hour. DNA probes (antisense to
two mature miRNA sequences) were end-labeled with
[γ-32P] ATP (GE Healthcare, Piscataway, NJ) using a
mirVana Probe & Marker Kit (Ambion, Austin, TX).
Pre-hybridization, hybridization and washes were carried
out at 42°C using ULTRAhyb-Oligo hybridization buffer
according to the manufacturer’s instructions (Ambion,
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an internal control to account for loading differences
between samples.
Confirmation of differentially expressed miRNAs by TaqMan
miRNA assay
To determine the expression of miRNAs by quantitative
RT-PCR (qRT-PCR), TaqMan miRNA assays were per-
formed. The specific stem-loop RT primers for miR-206,
miR-451 and U6 were obtained commercially from
Applied Biosystems (Foster City, CA). In brief, cDNA
was synthesized from total RNA by using the miRNA
specific primers according to the protocol of TaqMan
Micro RNA Assays (Applied Biosystems, CA). Reverse
transcriptase reactions contained 10 ng of RNA samples,
3 μl of 50 nM stem loop RT primer and reagents from
the TaqMan MiRNA Reverse Transcription Kit (Applied
Biosystems, CA). The 15 μl reactions were incubated for
30 min at 16°C, 30 min at 42°C and 5 min at 85°C, and
then held at 4°C. Real-time PCR was performed using
gene specific probes and a pair of primers and TaqMan
2X Universal PCR Master Mix (No AmpErase UNG)
(Applied Biosystems, CA). The 20 μl PCR reactions
included 1.33 μl cDNA products, 10 μl PCR master mix,
and 1 μl 20X TaqMan MiRNA Assay mix (Applied Bio-
systems, CA). These reactions were incubated at 95°C
for 10 min, followed by 40 cycles at 95°C for 10 s, 60°C
for 40 s and 72°C for 1 s using an ABI 7900 Realtime
PCR instrument (Applied Biosystems, CA). All reactions
were run in triplicate. The threshold cycle was defined
as the fractional cycle number at which the fluorescence
passes the fixed threshold. The expression levels of miR-
206 and miR-451 in each sample were measured in
terms of threshold cycle value and normalized to U6
expression using 2-ΔΔCT [48].
miRNA prediction and validation
Target prediction
The chicken (Gallus gallus) Unigene database (NCBI)
and the miRNA target prediction algorithm miRanda 3.1
(http://www.microran.org/microrna/getDownloads.do)
were employed to predict potential targets of all the dif-
ferentially expressed miRNAs. For miRanda, default
parameters were used with the following exceptions: the
score was set to ≥ 130 and the free energy was set
to ≤−16 kCal/mol. The predicted targets were further fil-
tered using more stringent criteria in which they must
contain either (1) a match between nucleotides 2–8 of
the miRNA with the target sequence or (2) a match be-
tween nucleotides 2–7 and 13–16 of the miRNA with
the target sequence (G:U base-pairing was tolerated). A
set of target genes containing miR-146a binding sites
within their 3´UTRs were selected for further analysis
using a dual luciferase reporter assay.Insertion of target sequences into psiCHECK-2
For each potential target gene, the region of 3´UTR
flanking the miR-146a binding sites was PCR amplified
from Red Jungle Fowl genomic DNA using gene specific
primers (Additional file 4: Table S4). Each PCR product
was cloned into the 3´UTR of the Renilla reporter gene
in the psiCHECK-2 vector (Promega, WI) using NotI
and XhoI restriction sites from the multicloning site.
Construction of RCAS viruses expressing chicken miR-146a
The previous described RCASBP(A)-miR vector [49] was
used to ectopically express miR-146a. In order to pro-
duce RCAS viruses expressing chicken miR-146a, an
entry vector was constructed using PAGE purified 76-nt
forward and 68-nt reverse oligos (Invitrogen). Restriction
sites for SphI and NgoMIV were introduced at the
5´- and 3´-ends, respectively. Forward and reverse oligos
were mixed at a final concentration of 1 μM, denatured
at 95°C for 20 sec and annealed at RT to generate a
short double-stranded DNA fragment. The fragment
was then cloned into the pENTR3C-miR-SphNgo vector
at the SphI and NgoMIV restriction sites. The RCASBP
(A)- miR-146a vector was generated via a recombination
between the pENTR3C- miR-146a entry vector and
RCASBP(A)-YDV gateway destination vector using a LR
clonase kit (Invitrogen, CA). To produce miR-146a
expressing viruses (RCAS- miR-146a), the RCASBP
(A)-miR146a plasmid vector was transfected into DF-1
cells, a chicken embryo fibroblast continuous cell line,
using FuGENE 6 (Promega, WI). Virus stock was har-
vested at day 6 post transfection and titer was deter-
mined using immunofluorescence staining with the
monoclonal 3 C2 antibody against the RSV/ALV gag
protein (Developmental Studies Hybridoma Bank, Uni-
versity of Iowa) and FITC-conjugated goat anti mouse
IgG (Invitrogen, CA). In addition, RCAS viruses (RCAS-
SC) expressing a scrambled control sequences were pro-
duced to serve as a negative control. Ectopic expression
of the miR-146a was validated using a miScript Reverse
Transcription kit and a miScript SYBR Green PCR kit
(Qiagen, CA).
Dual luciferase reporter assay
DF1 cells were infected with either RCAS-miR-146a or
RCAS-SC at a multiplicity of infection of 1 and main-
tained for 6 days in a 96-well plate in RPMI 1640 medium
supplemented with 1% heat-inactivated FBS, L-glutamine,
penicillin (100 U/ml), streptomycin (100 μg/ml), and fun-
gizone (4 μg/ml), at 37°C with 5% CO2. The psiCHECK-2
construct (100 ng) for each potential target gene, as well
as the scramble control, were then transfected into both
RCAS-miR-146a or RCAS-SC infected DF-1 cells using
FuGENE 6 (Promega, WI). Forty-eight hours post-trans-
fection, cells were washed with PBS and lysed in Passive
Wang et al. BMC Genomics 2012, 13:278 Page 14 of 15
http://www.biomedcentral.com/1471-2164/13/278Lysis Buffer (Promega, WI). For each transfection, firefly
and Renilla luciferase activities were determined using
the Dual-Luciferase Reporter Assay System (Promega,
WI) and a VictorLight 1420 luminescence counter
(PerkinElmer, MA). The Renilla luciferase signal was nor-
malized to the firefly luciferase signal. The normalized
Renilla luciferase activity was compared between the
RCAS-miR-146a and the RCAS-SC using student’s t-test
(P < 0.05). Triplicates for each target construct were per-
formed and the assay was repeated to confirm the results.Microarray analysis
Microarray experiment design: Four biological replicates
from infected and non-infected groups were used with dye
balance in order to prevent dye-bias during sample labeling.
Labeling and hybridization: The integrity of total RNA
samples was confirmed using Agilent Bioanalyzer 2100
Lab-on-chip system (Agilent Technologies, Palo Alto,
CA). Four hundred nano-grams (ng) of total RNA were
reverse-transcribed to cDNA during which a T7 pro-
moter sequence was introduced into the cDNA. T7
RNA polymerase-driven RNA synthesis was used for
preparation and labeling of RNA with Cy3 (or Cy5) dye.
Fluorescent cRNA probes were purified using Qiagen
RNeasy Mini Kit (Qiagen, Valencia, CA), and an equal
amount (825 ng) of Cy3 and Cy5 labeled cRNA probes
were hybridized to a 44 K chicken Agilent array (GEO
accession: GSE9416). The hybridized slides were washed
using a commercial kit package (Agilent Technol-ogies,
CA) and then scanned using a Genepix 4100A scanner
(Molecular Devices Corporation, Sunnyvale, CA) with a
tolerance of saturation setting of 0.005%.
Microarray data collection and analysis: For each
channel, the median of the signal intensity and local
background values were used. A Locally Weighted Lin-
ear Regression (LOWESS) normalization was applied to
remove signal intensity-dependent dye bias for each
array using R program. A mixed model that included the
fixed effects of dye (cy3 and cy5) and random effect of
slide and array was used to analyze the normalized data
by SAS (SAS institute, Cary, NC). P < 0.05 was consid-
ered significant. These data have been deposited in
GEO (Accession numbers: GSM879919, GSM879925,
GSM879936, GSM879937).Gene ontology
Functional annotations for differentially expressed genes
were performed through the use of the Database for An-
notation, Visualization and Integrated Discovery (DAVID)
[44-46]. Statistics related to over representation of func-
tional categories was based upon a Fisher’s Exact statistic
methodology similar to that described by Al-Shahrour
et al. [50]. A P< 0.05 was considered as significant.Additional files
Additional file 1: Table S1. The Novel miRNA.
Additional file 2: Table S2. Immune related targets of differentially
expressed miRNAs.
Additional file 3: Table S3. Enriched GO terms in biological process of
each comparison.
Additional file 4: Table S4. Primer table.
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